×
About 103 results

ALLMedicine™ Solar Urticaria Center

Research & Reviews  34 results

Ultraviolet A rush hardening for chronic actinic dermatitis: Pilot treatment outcomes.
https://doi.org/10.1111/1346-8138.15667
The Journal of Dermatology; Wang T, Gong Y et. al.

Dec 3rd, 2020 - Chronic actinic dermatitis (CAD) is a common debilitating photodermatosis. Patients often have to completely avoid outdoor activities, which severely impacts their quality of life. Phototherapy is effective for CAD and seems to increase patients' ...

Papular Urticaria
https://emedicine.medscape.com/article/1051461-overview

Mar 16th, 2020 - Overview Papular urticaria is a common and often annoying disorder manifested by chronic or recurrent papules caused by a hypersensitivity reaction to the bites of mosquitoes, fleas, bedbugs, and other insects. Individual papules may surround a wh...

Papular Urticaria 
https://emedicine.medscape.com/article/1051461-print

Mar 16th, 2020 - Papular urticaria is a common and often annoying disorder manifested by chronic or recurrent papules caused by a hypersensitivity reaction to the bites of mosquitoes, fleas, bedbugs, and other insects. Individual papules may surround a wheal and d...

Cholinergic Urticaria 
https://emedicine.medscape.com/article/1049978-print

Mar 16th, 2020 - Background Cholinergic urticaria is one of the physical urticarias brought on by a physical stimulus. Although this stimulus might be considered to be heat, the actual precipitating cause is sweating. The definition and diagnostic testing of choli...

Characteristics and clinical significance of augmentation spectra in solar urticaria.
https://doi.org/10.1111/1346-8138.15234
The Journal of Dermatology References; Uetsu N, Nomura Y et. al.

Jan 22nd, 2020 - Solar urticaria has unique spectra, such as inhibition and augmentation. The clinical significance of these spectra, especially augmentation, is not well understood. Reported cases of solar urticaria with augmentation spectra are extremely rare in...

see more →

Clinicaltrials.gov  2 results

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)
https://clinicaltrials.gov/ct2/show/NCT00483496

Dec 22nd, 2017 - Commercially available external photoprotectors (EP) do not provide adequate protection against ultraviolet A (UVA) and visible wavelengths. The proposed medicinal product V0096 CR (formula RV3131A-MV1166) is a broad spectrum EP (bsEP). The ration...

Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
https://clinicaltrials.gov/ct2/show/NCT01360658

Jul 30th, 2013 - Solar urticaria is a rare but debilitating disease that can severely impact the quality of life, restricting outdoor activities.Treatment, based on sun protection and anti-histaminic drugs, is efficacious in 2 patients out of 3. In refractory pati...

see more →

News  4 results

Solar Urticaria Treated With Omalizumab
https://www.mdedge.com/dermatology/article/205157/urticaria/solar-urticaria-treated-omalizumab?channel=44
William C. Schaffenburg, MD, Karen T. Guerrero, MD et. al.

Jul 23rd, 2019 - To the Editor: First documented in 1904,1 solar urticaria is an IgE-induced condition that predominantly occurs in women aged 20 to 50 years. Worldwide prevalence and incidence information is lacking, but it is known to occur in up to 0.

Fast Five Quiz: Test Yourself on Key Aspects of Summer Skin Conditions
https://reference.medscape.com/viewarticle/898940_3

Jul 9th, 2018 - Treatment of solar urticaria can be frustrating. A combination of different modalities is often necessary, but the success of these methods is highly variable. Taking measures to avoid or minimize sun exposure is the most important step for patien...

Afamelanotide in the Treatment of Dermatologic Disease
https://www.medscape.com/viewarticle/905916

Abstract and Introduction Abstract Afamelanotide, an α-melanocyte stimulating hormone analogue, has become an emerging therapeutic option for a variety of skin conditions previously refractory to other treatments. Its efficacy has been demonstrate...

Afamelanotide Implants Effective For Erythropoietic Protoporphyria
https://www.mdedge.com/internalmedicine/article/18244/rheumatology/afamelanotide-implants-effective-erythropoietic
Bruce Jancin

GOTHENBURG, SWEDEN – A resorbable subcutaneous implant of afamelanotide significantly reduced painful phototoxic attacks in patients with erythropoietic protoporphyria in a year-long multinational clinical trial. Photo: (C) 2009 Lecha et al.

see more →

Patient Education  1 results see all →